Years
|
Variablea
|
Anti-VHD +/Nb
|
Prevalence % (95% CI)
|
pc
|
Crude OR (95% CI)
|
p-value
|
---|
2012–2017
|
Gender
|
0.132
| | |
Female
|
22/183
|
12 (7.6–17.6)
| |
1 (reference)
| |
Male
|
42/243
|
17.3 (12.7–22.6)
| |
0.654 (0.134–1.14)
|
0.134
|
Age groups (years)
|
0.204
| | |
< 12
|
1/11
|
9.1 (0.22–41.3)
| |
1 (reference)
| |
[12–20]
|
18/108
|
16.7 (10.2–25.1)
| |
0.814 (0.461–1.439)
|
0.480
|
[21–40]
|
41/301
|
13.6 (9.9–18.0)
| |
0.690 (0.394–1.208)
|
0.218
|
> 40
|
4/6
|
66.7 (22.3–95.7)
| |
8.852 (1.449–54.074)
|
0.005
|
Regions
|
0.011
| | |
Center
|
54/377
|
14.3 (10.9–18.3)
| |
1 (reference)
| |
East
|
4/10
|
40 (12.2–73.8)
| |
3.956 (1.084–14.43)
|
0.037
|
Littoral
|
2/5
|
40 (5.2–85.3)
| |
0.259 (0.042–1.582)
|
0.143
|
North West
|
1/2
|
50 (1.2–98.7)
| |
0.175 (0.011–2.826)
|
0.219
|
South
|
3/6
|
50 (11.8–88.2)
| |
5.885 (1.161–29.83)
|
0.032
|
Adamawa
|
0/1
|
0
|
–
|
–
|
–
|
North
|
0/2
|
0
|
–
|
–
|
–
|
West
|
0/20
|
0
|
–
|
–
|
–
|
South West
|
0/3
|
0
|
–
|
–
|
–
|
Years
|
0.195
| | |
2012
|
8/35
|
22.9 (10.4–40.1)
| |
1 (reference)
| |
2013
|
12/51
|
23.5 (12.8–37.5)
| |
0.523 (0.257–1.064)
|
0.074
|
2014
|
7/76
|
9.2 (3.7–18.1)
| |
1.918 (0.838–4.387)
|
0.123
|
2015
|
13/89
|
14.6 (8.0–23.7)
| |
1.042 (0.539–2.016)
|
0.902
|
2016
|
14/114
|
12.3 (6.8–19.7)
| |
1.363 (0.722–2.574)
|
0.340
|
2017
|
10/61
|
16.4 (8.2–28.1)
| |
0.886 (0.424–1.850)
|
0.746
|
2012
|
Gender
|
0.286
| | |
Female
|
4/12
|
33.3 (9.9–65.11)
| |
1 (reference)
| |
Male
|
4/23
|
17.4 (4.9–38.78)
|
2.375 (0.473–11.92)
|
0.293
|
Age groups (years)
|
0.552
| | |
[12–20]
|
2/6
|
33.3 (4.3–77.72)
| |
1 (reference)
| |
[21–40]
|
5/27
|
18.5 (6.3–38.08)
| |
0.379 (0.067–2.13)
|
0.271
|
> 40
|
1/2
|
50 (1.2–98.74)
| |
3.714 (0.205–67.14)
|
0.507
|
Regions
|
0.156
| | |
Center
|
7/33
|
21.2 (8.9–38.90)
| |
1 (reference)
| |
Littoral
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
2013
|
Gender
|
0.633
| | |
Female
|
4/20
|
20 (5.7–43.66)
| |
1 (reference)
| |
Male
|
8/31
|
25.8 (11.85–44.61)
|
0.767 (0.196–3.003)
|
0.703
|
Age groups (years)
|
0.250
| | |
[12–20]
|
2/7
|
28.6 (3.66–70.95)
| |
1 (reference)
| |
[21–40]
|
9/42
|
21.4 (10.29–36.81)
| |
0.563 (0.117–2.706)
|
0.761
|
> 40
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
Regions
| | | |
Center
|
12/50
|
24 (13.06–38.16)
|
0.575
|
–
|
–
|
2014
|
Gender
|
0.103
| | |
Female
|
1/33
|
3 (0.777–15.75)
| |
1 (reference)
| |
Male
|
6/43
|
14 (5.29–27.93)
|
0.193 (0.02–1.686)
|
0.137
|
Age groups (years)
|
0.777
| | |
[12–20]
|
3/20
|
15 (3.2–37.89)
| |
1 (reference)
| |
[21–40]
|
4/52
|
7.7 (2.1–18.53)
| |
0.583 (0.12–2.83)
|
0.452
|
Regions
|
0.013
| | |
Center
|
5/67
|
7.5 (2.4–16.56)
| |
1 (reference)
| |
South
|
2/3
|
66.7 (9.4–99.15)
| |
27.20 (2.089–354.15)
|
0.012
|
2015
|
Gender
|
0.103
| | |
Female
|
3/39
|
7.7 (1.6–20.87)
| |
1 (reference)
| |
Male
|
10/50
|
20 (10.03–33.71)
|
0.33 (0.085–1.307)
|
0.115
|
Age groups (years)
|
0.239
| | |
< 12
|
1/1
|
100 (2.5–100)
| |
1 (reference)
| |
[12–20]
|
3/25
|
12 (2.5–31.21)
| |
0.917 (0.255–3.290)
|
0.894
|
[21–40]
|
8/61
|
13.1 (5.8–24.21)
| |
0.694 (0.205–2.35)
|
0.431
|
> 40
|
1/2
|
50 (1.2–98.74)
| |
6.25 (0.366–106.76)
|
0.206
|
Regions
|
0.039
| | |
Center
|
11/78
|
14.1 (7.2–23.83)
| |
1 (reference)
| |
East
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
North west
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
2016
|
Gender
|
0.477
| | |
Female
|
7/47
|
14.9 (6.2–28.30)
| |
1 (reference)
| |
Male
|
7/67
|
10.4 (4.3–20.34)
|
1.55 (0.487–4.604)
|
0.479
|
Age groups (years)
|
0.830
| | |
[12–20]
|
5/29
|
17.2 (5.8–35.77)
| |
1 (reference)
| |
[21–40]
|
8/81
|
9.9 (4.3–18.5)
| |
0.493 (0.157–1.55)
|
0.227
|
> 40
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
Regions
|
0.029
| | |
Center
|
11/98
|
11.2 (5.7–19.19)
| |
1 (reference)
| |
East
|
2/4
|
50 (6.7–93.24)
| |
8.167 (1.052–63.41)
|
0.045
|
South
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
2017
|
Gender
|
0.120
| | |
Female
|
3/22
|
9.4 (2.9–34.91)
| |
1 (reference)
| |
Male
|
7/29
|
24.1 (10.29–43.54)
| |
0.325 (0.075–1.402)
|
0.132
|
Age groups (years)
|
0.723
| | |
[12–20]
|
3/21
|
14.3 (3.04–36.34)
| |
1 (reference)
| |
[21–40]
|
7/38
|
18.4 (7.7–34.32)
| |
0.664 (0.154–2.874)
|
0.584
|
Regions
|
0.114
| | |
Center
|
8/51
|
15.7 (7.02–28.58)
| |
1 (reference)
| |
East
|
1/5
|
20 (0.5–71.64)
| |
1.306 (0.130–13.08)
|
0.821
|
Littoral
|
1/1
|
100 (2.5–100)
| |
–
|
–
|
- aInformation from available data
- b number of tested patients by categories may not sum to total because of missing data; %, percentage of anti-HDV prevalence among HBsAg positive patients; +, positive; N, total
- pc, estimated by Chi-squared of Pearson test; p, it is the p value associated with the OR; OR, odds ratio; CI, confidence interval